{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:47:22Z","timestamp":1793915242460,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007658","name":"Crohn's and Colitis Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.gastro.2021.07.009","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T01:11:28Z","timestamp":1626743488000},"page":"1540-1551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Anti-Microbial Antibody Response is Associated With Future Onset of Crohn\u2019s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk"],"prefix":"10.1053","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-0047","authenticated-orcid":false,"given":"Sun-Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Williams","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Espin-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Raygoza Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle I.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Leibovitzh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Goethel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Deslandres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Aumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Hillary","family":"Steinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Q.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Princen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Croitoru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.07.009_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.07.009_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.009_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","article-title":"Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease","volume":"126","author":"Mow","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial flagellin is a dominant antigen in Crohn disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2021.07.009_bib5","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn\u2019s disease","volume":"128","author":"Targan","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.31.5.536","article-title":"Antibody to selected strains of Saccharomyces cerevisiae (baker\u2019s and brewer\u2019s yeast) and Candida albicans in Crohn\u2019s disease","volume":"31","author":"McKenzie","year":"1990","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.07.009_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn\u2019s disease\u2013associated immune responses to auto- and microbial antigens","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2036.2011.04932.x","article-title":"The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn\u2019s disease: impact of resection on ASCA serum levels in Crohn\u2019s disease","volume":"35","author":"Eser","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.07.009_bib9","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/j.1572-0241.2003.07673.x","article-title":"Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn\u2019s disease during steroid and 5-aminosalicylic acid treatment","volume":"98","author":"Teml","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.009_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cgh.2008.04.032","article-title":"Increased immune reactivity predicts aggressive complicating Crohn\u2019s disease in children","volume":"6","author":"Dubinsky","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.009_bib11","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/apt.13641","article-title":"Serologic microbial associated markers can predict Crohn\u2019s disease behaviour years before disease diagnosis","volume":"43","author":"Choung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.07.009_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2012-302717","article-title":"Serological markers predict inflammatory bowel disease years before the diagnosis","volume":"62","author":"Schaik","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.07.009_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.07.009_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 y before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib15","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of Crohn\u2019s disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib16","article-title":"Sa1816 \u2013 elevated fecal calprotectin in healthy first degree relatives of patients with Crohn\u2019s disease is associated with future diagnosis of Crohn\u2019s disease","volume":"156","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2016.01.016","article-title":"Association between circulating levels of c-reactive protein and interleukin-6 and risk of inflammatory bowel disease","volume":"14","author":"Lochhead","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.009_bib18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ng.3693","article-title":"Association of host genome with intestinal microbial composition in a large healthy cohort","volume":"48","author":"Turpin","year":"2016","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial flagellin is a dominant antigen in Crohn disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2021.07.009_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A\u00a0reference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajhg.2015.09.001","article-title":"Modeling linkage disequilibrium increases accuracy of polygenic risk scores","volume":"97","author":"Vilhj\u00e1lmsson","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib25","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/bimj.201900120","article-title":"Causal mediation analysis in nested case-control studies using conditional logistic regression","volume":"62","author":"Kim","year":"2020","journal-title":"Biometrical J"},{"key":"10.1053\/j.gastro.2021.07.009_bib26","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.07.009_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"key":"10.1053\/j.gastro.2021.07.009_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.07.009_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.gastro.2021.03.064","article-title":"Human microbiota flagellins drive adaptive immune responses in Crohn\u2019s disease","volume":"161","author":"Alexander","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","article-title":"Anti-Saccharomyces Cerevisiae Antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families","volume":"7","author":"Vermeire","year":"2001","journal-title":"Inflammatory Bowel Dis"},{"key":"10.1053\/j.gastro.2021.07.009_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajhg.2018.09.009","article-title":"Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders","volume":"103","author":"Ligthart","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2021.07.009_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.gastro.2016.05.050","article-title":"Commensal-specific CD4+ cells from patients with Crohn\u2019s disease have a T-Helper 17 inflammatory profile","volume":"151","author":"Calder\u00f3n-G\u00f3mez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.009_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jgh3.12068","article-title":"Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn\u2019s disease activity: fecal calprotectin and disease location in IBD","volume":"2","author":"Zittan","year":"2018","journal-title":"JGH Open"},{"key":"10.1053\/j.gastro.2021.07.009_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5217\/ir.2018.00114","article-title":"Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn\u2019s disease?: a systematic review","volume":"17","author":"Simon","year":"2019","journal-title":"Intest Res"},{"key":"10.1053\/j.gastro.2021.07.009_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/00365521.2015.1008035","article-title":"Impact of disease location on fecal calprotectin levels in Crohn\u2019s disease","volume":"50","author":"Gecse","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.009_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cgh.2019.05.061","article-title":"Genetic and inflammatory biomarkers classify small intestine inflammation in asymptomatic first-degree relatives of patients with Crohn\u2019s disease","volume":"18","author":"Taylor","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.009_bib37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cgh.2017.02.028","article-title":"Increased intestinal permeability in relatives of patients with Crohn\u2019s disease is not associated with small bowel ulcerations","volume":"15","author":"Teshima","year":"2017","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521032431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521032431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:35:54Z","timestamp":1758036954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521032431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0016508521032431"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.07.009","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Microbial Antibody Response is Associated With Future Onset of Crohn\u2019s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}